期刊文献+

鼻腔滴入胰岛素改善2型糖尿病大鼠海马阿尔茨海默病样改变 被引量:12

Intranasal insulin treatment ameliorates Alzheimer disease-like changes in hippocampus in a rat model of type 2 diabetes
下载PDF
导出
摘要 目的:2型糖尿病(type 2 diabetes,T2D)时大脑出现胰岛素水平下降及胰岛素信号通路下调,使大脑海马tau蛋白出现过度磷酸化的阿尔茨海默病(Alzheimer disease,AD)样改变。本研究选取2型糖尿病大鼠,皮下注射及鼻腔滴入胰岛素,观察大脑AD样病变的改变,并探讨其机制。方法:高糖、高脂、高蛋白喂饲3个月后链脲佐菌素腹腔注射制备T2D大鼠模型。运用2种方法干预:鼻腔滴入胰岛素(T2D+I-I)及皮下注射胰岛素(T2D+S-I)。检测血浆葡萄糖、血浆胰岛素和脑脊液胰岛素水平,免疫印记方法检测大脑海马总tau蛋白和tau蛋白部分位点磷酸化状态、胰岛素信号转导途径中关键酶磷脂酰肌醇3-激酶(phosphatidylinositol 3-kinase,PI3K)/Akt及糖原合成激酶3β(glycogen synthase kinase 3β,GSK-3β)活性。结果:T2D组大鼠血浆葡萄糖及胰岛素水平显著升高,脑脊液胰岛素水平显著降低,大脑海马组织中tau蛋白呈过度磷酸化状态,PI3K/Akt活性下降,GSK-3β磷酸化水平升高;T2D+I-I组大鼠血浆胰岛素及葡萄糖水平无显著改变,但大脑海马tau蛋白过度磷酸化状态显著好转,PI3K/Akt活性显著升高,GSK-3β活性显著下降;T2D+S-I组大鼠血糖显著下降,但血浆及脑脊液胰岛素水平无显著改变,大脑海马tau蛋白磷酸化水平有轻度改善,但变化不显著。结论:运用鼻腔滴入胰岛素可减轻T2D时大脑海马组织的AD样病变;外周皮下胰岛素注射对T2D时AD样病变无明显作用。 AilM: To investigate Alzheimer disease (AD) -like changes and 2 key components of the insulin signaling pathway in the brain of a rat model of type 2 diabetes (T2D) after insulin treatment. METHODS: The rat model of T2D was established by feeding a high-protein, high-glucose and high-fat diet followed by intrasubcutaneous injection of streptozocin. Intranasal insulin treatment (T2D + I-I) and subcutaneous insulin injection (T2D + S-I) were applied to ele- vate the insulin level in the brain. The insulin levels in plasma and cerebrospinal fluid as well as the concentration of plas- ma glucose were measured. Total tan level, the phosphorylation level of tau at some phosphorylation sites, and the activa- tion of GSK-3β and Akt in subcutaneous of the rats were also analyzed by Western blotting. RESULTS: AD-like changes, decreased Akt activation and over-activation of GSK-3β in the hippocampus of the T2D rats were observed. Intranasal insu- lin treatment for 4 weeks normalized the levels of Akt and GSK-3β, as well as reduced the AD-like changes in the bippo- campus of the T2D rats, whereas the treatment with insulin by subcutaneous injection for 4 weeks had minimal effects on the levels of GSK-3β and tau phosphorylation in the hippocampus. CONCLUSION: Intranasal insulin treatment, but not subcutaneous insulin treatment, might decrease the risk of AD in T2D rats by reducing AD-like changes and up-regulating the impaired insulin signaling pathway in the hippocampus, indicating the potential use of intranasal insulin delivery for treatment of AD.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2013年第1期56-61,共6页 Chinese Journal of Pathophysiology
基金 国家自然科学基金青年基金资助项目(No.81100582) 教育部博士点新教师基金资助项目(No.200804871047) 湖北省卫生厅一般项目(No.JX5B04)
关键词 阿尔茨海默病 2型糖尿病 胰岛素 TAU蛋白过度磷酸化 胰岛素信号途径 Alzheimer disease Type 2 diabetes Insulin Tau hyperphosphorylation Insulin signaling pathway
  • 引文网络
  • 相关文献

参考文献19

  • 1Stranahan AM,Mattson MP. Metabolic reserve as a deter- minant of cognitive aging[ J]. J Alzheimers Dis, 2012, 30 (Suppl 2) : S5-S13.
  • 2Ott A, Stolk RP, van Harskamp F, et al. Diabetes melli- tus and the risk of dementia: the Rotterdam Study [ J ]. Neurology, 1999, 53(9) : 1937-1942.
  • 3Schrijvers EM, Witteman JC, Sijbrands E J, et al. Insulin metabolism and the risk of Alzheimer disease: the Rotter- dam Study[J]. Neurology, 2010, 75(22) : 1982-1987.
  • 4Iqbal K, Liu F, Gong CX, et al. Tau in Alzheimer dis- ease and related tauopathies [ J ]. Curr Alzheimer Res, 2010, 7(8): 656-664.
  • 5Kim B, Backus C, Oh S, et ai. Increased tau phosphoryl- ation and cleavage in mouse models of type 1 and type 2 diabetes [ J ]. Endocrinology, 2009, 150 ( 12 ) : 5294- 5301.
  • 6Liu Y, Liu F, Grundke-Iqbal I, et al. Brain glucose transporters, O-GlcNAcylation and phosphorylation of tan in diabetes and Alzheimer's disease [ J ]. J Neurochem, 2009, 111(1) : 242-249.
  • 7Qu z, Jiao Z, Sun X, et al. Effects of streptozotocin-in- duced diabetes on tan phosphorylation in the rat brain [ J]. Brain Res, 2011, 1383: 300-306.
  • 8杨雁,胡蜀红,张建华,张木勋,龚成新.肥胖及2型糖尿病大鼠Alzheimer病样Tau蛋白过度磷酸化修饰及机制探讨[J].生物化学与生物物理进展,2006,33(5):458-464. 被引量:19
  • 9McNay EC,Recknagel AK. Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes [ J ]. Neurobiol Learn Mem, 2011,96(3) : 432-442.
  • 10Holscher C. Diabetes as a risk factor for Alzheimer's dis- ease: insulin signalling impairment in the brain as an al- ternative model of Alzheimer's disease [ J ]. Biochem Soc Trans, 2011, 39(4): 891-897.

二级参考文献60

  • 1胡志红,田青,王建枝.丝氨酸/苏氨酸蛋白磷酸酯酶在tau蛋白异常磷酸化中的作用[J].生理科学进展,2006,37(2):173-174. 被引量:1
  • 2陈勤,高晨曦,葛礼浩.远志皂苷对脑定位注射Aβ_(1-40)拟AD大鼠脑内神经形态病理学变化的影响[J].激光生物学报,2006,15(3):294-298. 被引量:32
  • 3陈勤,李磊珂.远志皂苷对β淀粉样蛋白1-40诱导的体外培养皮层神经细胞损伤的保护作用[J].中国中药杂志,2007,32(13):1336-1339. 被引量:37
  • 4包新民 舒斯之.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.39-40.
  • 5Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Mcd, 2010, 362(12): 1090-1101.
  • 6Han W, Li C. Linking type 2 diabetes and Alzheimer's disease [J]. Proc Natl Acad SciU S A, 2010, 107(15): 6557-6558.
  • 7Strachan MW, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly [J]. Nat RevEndoerinol, 2011, 7(2): 108-114.
  • 8Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors[J]. Lancet Neurol, 2008, 7(9) : 812-826.
  • 9Plaschke K, Kopitz J, Siegelin M, et al. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-hke changes in Tg2576 AbetaPP- overexpressing mice[J]. J Alzheimers Dis, 2010, 19(2) : 691- 704.
  • 10Belgardt BF, Bruning JC. CNS leptin and insulin action in the control of energy homeostasis [ J]. Ann N Y Acad Sci, 2010, 1212:97-113.

共引文献53

同被引文献92

引证文献12

二级引证文献45

;
使用帮助 返回顶部